No NFO data available for this page.

3 Year return

18.23%
20222022Jul '22Jul '2220232023Jul '23Jul '2320242024
Launched on January 2013 (12 years)

Investment Details

₹500

Minimum SIP Amount

₹1000

Minimum one time investment

Fund has no lock-in period

Calculate Returns

Based on past performance of this fund

ENTER AMOUNT

Your Investment ₹18,000
Gain
  • 33.81%
  • ₹6,085
  • Total Value
  • ₹24,085

Risk Involved

scale

Your principal will be at

Very High Risk

Scheme Information

Asset Under Management

₹5487.53 Cr.

Expense Ratio

1.32% (inclusive of GST)

Exit Load

Redemption / Switch out within 12 months from the dats of allotment - i) upto 10% of the allotted Units - NIL ii) beyond 10% of the allotted Units - 1.00% Redemption / Switch out after 12 months from the date of allotment - NIL

Ratings

ARQ Rating
4.5

Ratings by other agencies

3
3
3

Tax Implications

Withdrawal within 1 year

Exit load + 15% tax on gains

Withdrawal after 1 year

10% tax on gains over ₹1 Lakh per financial year

Fund Holdings

Holdings
₹5487.53Crores
Other Holdings% of Asset
Infosys3.04 %
Larsen & Toubro2.65 %
M & M2.44 %
GSEC20362.31 %
GSEC20342.27 %
Axis Bank2.17 %
Net CA & Others2.1 %
IndusInd Bank1.82 %
GAIL (India)1.73 %
Interglobe Aviat1.7 %
GSEC20331.58 %
Bharti Airtel1.56 %
Tata Motors-DVR1.48 %
HCL Technologies1.42 %
GSEC20531.37 %
Aditya Birla Cap1.2 %
Hindalco Inds.1.19 %
Bajaj Auto1.11 %
Phoenix Mills1.09 %
GE Shipping Co0.98 %
Aurobindo Pharma0.98 %
Raymond0.93 %
Nippon Life Ind.0.92 %
REC Ltd0.92 %
HDFC Bank0.92 %
Kerala 20340.91 %
REC Ltd0.9 %
Oracle Fin.Serv.0.88 %
Oil India0.85 %
Apollo Tyres0.84 %
G R Infraproject0.8 %
Power Grid Corpn0.78 %
Shriram Finance0.77 %
Vedanta0.76 %
Marksans Pharma0.75 %
Emami0.75 %
Canara Bank0.73 %
Ajanta Pharma0.73 %
Max Financial0.71 %
Indus Towers0.71 %
Federal Bank0.7 %
Coromandel Inter0.69 %
Cipla0.67 %
Gland Pharma0.65 %
Dalmia BharatLtd0.65 %
GHCL0.65 %
Zydus Lifesci.0.62 %
Crompton Gr. Con0.58 %
Indian Bank0.58 %
Mahindra Holiday0.56 %
Glenmark Pharma.0.56 %
Fortis Health.0.55 %
Shriram Finance0.55 %
Indo Count Inds.0.53 %
Sundaram Finance0.53 %
Jindal Stain.0.51 %
S P Apparels0.5 %
Caplin Point Lab0.5 %
Star Health Insu0.49 %
Bharti Airtel PP0.49 %
Indraprastha Gas0.48 %
NIIT Learning0.47 %
Jamnagar Utiliti0.46 %
I R F C0.46 %
HDFC Bank0.46 %
Power Fin.Corpn.0.46 %
Power Fin.Corpn.0.46 %
S I D B I0.46 %
Andhra Pradesh 20360.46 %
Union Bank (I)0.45 %
NABFID0.45 %
N A B A R D0.45 %
HDB FINANC SER0.45 %
LIC Housing Fin.0.45 %
I R F C0.45 %
TMF Holdings0.45 %
Escorts Kubota0.42 %
JK Paper0.36 %
Rajasthan 20390.35 %
Bharti Hexacom0.2 %
St Bk of India0.18 %
Piramal Capital0.15 %
Uttar Pradesh 20400.14 %
TBILL-364D0.12 %
Maharashtra 20390.1 %
Gsec20390.09 %
Tamil Nadu 20270.09 %
C C I0.08 %
Uttar Pradesh 20390.05 %
Maharashtra 20280.04 %
Power Fin.Corpn.0.02 %
RAJASTHAN 20260.02 %
Life Insurance0.01 %
GSEC20270.01 %
Maharashtra 20270.01 %
Yes Bank0 %

UTI Mutual Fund Managers

VS

V Srivatsa

Fund Manager since Dec 2014

View Details

Fund House Details

UTI Mutual Fund

UTI Mutual Fund Asset management company

AUM ₹290,993.03 Cr.
No. of Schemes 250
Setup Date January 2003

Peer Comparison

Comparison with other similar funds

Schemes by UTI Mutual Fund

List of mutual fund schemes by AMC

Funds 3 Years Returns
18.24%
scheme logo

Hybrid . Aggressive Hybrid Fund

UTI Aggressive Hybrid Fund Direct Plan Growth

18.23%
6.16%

About UTI Hybrid Equity Fund Direct Plan Growth

UTI Hybrid Equity Fund Direct Plan Growth is an aggressive hybrid fund that is operating a portfolio with the goal of generating income and capital growth. The scheme, which falls under the UTI Mutual Fund house, has a turnover ratio that is moderately higher due to the investment style. This large cap balanced fund has a value orientation that follows a top-down approach for large caps and a bottom-up approach for mid and small-cap stocks. This scheme has the CRISIL Hybrid 25+75 Aggressive Index as its benchmark.

Investment Objective of The Scheme

The main goal of UTI Hybrid Equity Fund Direct Plan Growth is to produce long-term capital appreciation through investments primarily in equities and equity-linked instruments of businesses with a range of market capitalisations. In order to provide consistent income, the fund additionally makes investments in debt and money market securities.

Key Features of The Fund

5-year return 16.69%
Expense Ratio 1.32%
Fund Manager V Srivatsa
Fund Size ₹5487.53 Cr
Risk Profile Very High

Is This Scheme Right for Me?

Investors that are looking for long-term capital appreciation, and investment in debt and money market assets (fixed income securities) and equity instruments, may consider investing in UTI Hybrid Equity Fund Direct Plan Growth. If unsure whether a product is right for you, you can speak with your financial advisors. This scheme is best suited for investments with a time horizon of at least five years.

AMC Contact Details

Name UTI Mutual Fund
Launch Date January 2003
Addresss First Floor, Unit No. 2, Block ‘B’, JVPD Scheme, Gulmohar Cross Road No. 9, Andheri (West), Mumbai – 400049.
Contact 1800 266 1230(+91) 022 6227 8000022 – 68990800
Email service@uti.co.in
Website https://www.utimf.com/

Disclaimer: Mutual funds are subject to market risk. Read all scheme-related documents carefully to make informed-decision.

Combat Inflation with SIP Investments

Compound growth and steady contributions through SIPs balance the negative effects of inflation, guaranteeing that your money increases faster than inflation. Use Angel One's free SIP calculator online to estimate potential returns and plan your inflation-hedging investment strategy effectively.

FAQs

What is today's NAV of UTI Aggressive Hybrid Fund?

NAV, or Net Asset Value, is the price of a single unit of a mutual fund. It is calculated by dividing the current value of holdings held by the mutual fund scheme at the end of the day by the total number of units issued. The NAV changes every day. The NAV of UTI Aggressive Hybrid Fund on May 29 2024, is ₹382.0065